Perspectives of Health Professionals Towards Neonatal Genetic Screening

Q4 Pharmacology, Toxicology and Pharmaceutics Current Pharmacogenomics and Personalized Medicine Pub Date : 2022-02-25 DOI:10.2174/1875692119666220225140848

T. A. Abeje

{"title":"Perspectives of Health Professionals Towards Neonatal Genetic Screening","authors":"T. A. Abeje","doi":"10.2174/1875692119666220225140848","DOIUrl":null,"url":null,"abstract":"\n\nAfter the completion of the human genome, the project has created opportunities of improving the diagnosis, prevention, and treatment of disease. However, limitations of health professionals (HPs), genetic knowledge, technological resources, and shortage of scientific researches prevent addressing genetic screening globally.\n\n\n\nTo assess HPs knowledge, attitude, and future perspective towards neonatal genetic screening.\n\n\n\nThe study was carried out in a cross-sectional survey. A simple random sampling technique was used to select health centers and health care, professionals. Questioners were used to assessing HPs knowledge, attitude, and future perspectives towards genetic disease screening.\n\n\n\nAmong the total of 384 HPs, 79.7% and 20.3% had good and poor knowledge on the basic idea of genetic screening, respectively. Similarly, 92.4% and 7.6% of HPs had good and poor knowledge, respectively, on the parental history of genetic disease. Besides, 68.8% and 31.3% of HPs had good and poor knowledge on the possibility of treating genetic diseases. Lastly, 81.3% and 18.5% of HPs had a positive and negative attitude towards genetic screening.\n\n\n\nThe majority of HPs were found good genetic knowledge and a positive attitude on the basic idea of genetic screening, parental history, and the possibility of treating genetic disease, respectively. However, the practice of genetic screening is not addressed in Ethiopia yet. Genetic HPs and non-genetic HPs have to be encouraging the concerned bodies including the governmental system to implement genetic screening in Ethiopia.\n","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1875692119666220225140848","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 0

Abstract

After the completion of the human genome, the project has created opportunities of improving the diagnosis, prevention, and treatment of disease. However, limitations of health professionals (HPs), genetic knowledge, technological resources, and shortage of scientific researches prevent addressing genetic screening globally. To assess HPs knowledge, attitude, and future perspective towards neonatal genetic screening. The study was carried out in a cross-sectional survey. A simple random sampling technique was used to select health centers and health care, professionals. Questioners were used to assessing HPs knowledge, attitude, and future perspectives towards genetic disease screening. Among the total of 384 HPs, 79.7% and 20.3% had good and poor knowledge on the basic idea of genetic screening, respectively. Similarly, 92.4% and 7.6% of HPs had good and poor knowledge, respectively, on the parental history of genetic disease. Besides, 68.8% and 31.3% of HPs had good and poor knowledge on the possibility of treating genetic diseases. Lastly, 81.3% and 18.5% of HPs had a positive and negative attitude towards genetic screening. The majority of HPs were found good genetic knowledge and a positive attitude on the basic idea of genetic screening, parental history, and the possibility of treating genetic disease, respectively. However, the practice of genetic screening is not addressed in Ethiopia yet. Genetic HPs and non-genetic HPs have to be encouraging the concerned bodies including the governmental system to implement genetic screening in Ethiopia.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

卫生专业人员对新生儿遗传筛查的看法

人类基因组完成后，该项目为改善疾病的诊断、预防和治疗创造了机会。然而，卫生专业人员的限制、遗传知识、技术资源和科学研究的缺乏阻碍了全球遗传筛查的解决。评估HPs对新生儿遗传筛查的知识、态度和未来观点。这项研究是在横断面调查中进行的。一种简单的随机抽样技术被用来选择卫生中心和卫生保健专业人员。提问者被用来评估HPs对遗传病筛查的知识、态度和未来观点。384名hp中，对遗传筛查基本概念了解较好的占79.7%，不了解的占20.3%。同样，92.4%和7.6%的hp对父母遗传病史的了解分别为良好和不佳。此外，68.8%和31.3%的HPs对遗传病治疗可能性的认识较好和较差。最后，81.3%和18.5%的HPs对遗传筛查持积极态度和消极态度。多数HPs对遗传知识有较好的认识，对遗传筛查的基本观念、亲代史和治疗遗传病的可能性持积极态度。然而，遗传筛查的做法在埃塞俄比亚还没有得到解决。遗传hp和非遗传hp必须鼓励包括政府系统在内的有关机构在埃塞俄比亚实施遗传筛查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Pharmacogenomics and Personalized Medicine Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

0.40

自引率

0.00%

发文量

期刊介绍： Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.